ArticleFuture oncology (London, England)2025

Real-world treatment and utilization of venetoclax for incident acute myeloid leukemia in a Medicare population.

Joshua A Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.